These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 22435404
21. The Influence of Haemostatic System Maturation on the Dose-Response Relationship of Unfractionated Heparin. Derbalah A, Duffull S, Moynihan K, Al-Sallami H. Clin Pharmacokinet; 2021 Apr; 60(4):491-499. PubMed ID: 33128209 [Abstract] [Full Text] [Related]
24. The monitoring of heparin administration by screening tests in experimental dogs. Mischke R, Jacobs C. Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088 [Abstract] [Full Text] [Related]
25. The APTT response of pregnant plasma to unfractionated heparin. Chunilal SD, Young E, Johnston MA, Robertson C, Naguit I, Stevens P, Galashan D, Oskamp ML, Brennan B, Ginsberg JS. Thromb Haemost; 2002 Jan; 87(1):92-7. PubMed ID: 11848463 [Abstract] [Full Text] [Related]
26. Correlation between activated clotting time and activated partial thromboplastin times. Smythe MA, Koerber JM, Nowak SN, Mattson JC, Begle RL, Westley SJ, Balasubramaniam M. Ann Pharmacother; 2002 Jan; 36(1):7-11. PubMed ID: 11816262 [Abstract] [Full Text] [Related]
27. Comparison of unfractionated heparin protocols using antifactor Xa monitoring or activated partial thrombin time monitoring. Frugé KS, Lee YR. Am J Health Syst Pharm; 2015 Sep 01; 72(17 Suppl 2):S90-7. PubMed ID: 26272899 [Abstract] [Full Text] [Related]
28. Effect of Subcutaneous Unfractionated Heparin Prophylaxis on Activated Partial Thromboplastin Time: A Retrospective Evaluation. Thompson MH, Wilson SH, Toussaint BL, Jordan CL, Hayes GL, McKinzie BP, Wolf BJ, Field LC. J Clin Anesth; 2016 Sep 01; 33():346-50. PubMed ID: 27555191 [Abstract] [Full Text] [Related]
29. Dextran sulfate included in factor Xa assay reagent overestimates heparin activity in patients after heparin reversal by protamine. Mouton C, Calderon J, Janvier G, Vergnes MC. Thromb Res; 2003 Sep 01; 111(4-5):273-9. PubMed ID: 14693175 [Abstract] [Full Text] [Related]
30. Effect of oral administration of unfractionated heparin (UFH) on coagulation parameters in plasma and levels of urine and fecal heparin in dogs. Erickson M, Hiebert LM, Carr AP, Stickney JD. Can J Vet Res; 2014 Jul 01; 78(3):193-201. PubMed ID: 24982550 [Abstract] [Full Text] [Related]
37. Suppression of intimal hyperplasia with low molecular weight heparin in a sheep model. Ao PY, Hawthorne WJ, Coombs R, Fletcher JP. Int Angiol; 1999 Jun 01; 18(2):131-9. PubMed ID: 10424369 [Abstract] [Full Text] [Related]